Reverse DCF
What growth does the market imply for NATHBIOGEN?
Working backwards from the current price to find the FCF growth assumption baked in.
aggressive
16.1% implied annual FCF growth
The market is pricing in above-average growth. Achievable for a high-quality business but leaves limited margin for error — any slowdown could hurt the price.
Current Price
₹169
Historical Growth
9.6%
FCF Yield
3.01%
Price / FCF
33.3x
Plain English
To justify today's price of $169.10, NATHBIOGEN.NS needs to grow its free cash flow at 16.1% per year for the next 10 years. That is 6.5% faster than its historical growth rate of 9.6%. This is optimistic but not impossible for a high-quality business. The stock leaves little room for error — any slowdown could hurt the price.
Adjust Assumptions
Growth Scenarios
What the stock is worth at different growth assumptions
| Scenario | FCF Growth | Implied IV | MoS vs Price |
|---|---|---|---|
| Half implied | 8.0% | ₹84 | -50.5% |
| Historical | 9.6% | ₹97 | -42.8% |
| GDP rate | 10.0% | ₹100 | -40.7% |
| Implied | 16.1% | ₹170 | +0.8% |
See full DCF analysis
Bear/base/bull scenarios, sensitivity heatmap, Monte Carlo, and more.
Run Full Analysis →This is an analytical tool, not investment advice. Implied growth is a mathematical inversion of the DCF model and depends on WACC and terminal growth assumptions. YieldIQ is not registered with SEBI as an investment adviser.